Robert F. Kennedy Jr. also disclosed that he had reached at least one settlement agreement with a company or individual that has accused him of “misconduct or inappropriate behavior.”

Senators had objected to the financial conflict posed by Robert F. Kennedy Jr.’s decision to retain a financial stake in lawsuits against a major drug company. It remains unclear whether any proceeds would be redirected.

If confirmed as health secretary, Robert F. Kennedy Jr. would oversee the Food and Drug Administration and other agencies that issue key decisions for drug companies.